Skip to main content
Up to 53% offSee the plans

News | Stocks | Iran

Loghman Pharmaceutical & Hygiene (DLGM) Lifts Six-Month Net Profit 258% as Gross Margin Rises From 29% to 62.3%

Sahmino Newsroom | 19 November 2026 | 2 days ago

DLGMup3.0%10,450rials18 November

Loghman Pharmaceutical & Hygiene (DLGM) lifted its net profit to 12,104 billion rials in audited six-month statements to 22 September 2026 (31 Shahrivar 1405), published on Codal on Thursday, 19 November 2026. That is 258% above the 3,383 billion rials of the same period a year earlier. The figures are the company's standalone statements.

Operating revenue rose from 10,297 to 28,189 billion rials (up 174%) and gross profit jumped from 2,988 to 17,575 billion rials, taking the gross margin from about 29% to 62.3%. Operating profit was 16,464 billion rials against 2,416 billion in the comparable period. Finance costs climbed from 610 billion to 1,729 billion rials. Basic earnings per share were reported at 1,183 rials against 330 rials.

The six-month net profit is about 1.9 times the profit for the whole of fiscal 1404, which was 6,474 billion rials on restated figures.

Reference:CodalThe original report

Sahmino context

What the prices have done since this story was published, and what Sahmino wrote around it

More from this market